CVI Investments, Inc. 13D/13G Filings for Candel Therapeutics, Inc. (CADL)

CVI Investments, Inc. 13D and 13G filings for Candel Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-07
4:09 pm
Sale
2024-12-31 13G Candel Therapeutics, Inc.
CADL
CVI Investments, Inc. 0
0.000%
-2,350,000decrease
(Position Closed)
Filing
2024-12-17
12:30 pm
Purchase
2024-12-13 13G Candel Therapeutics, Inc.
CADL
CVI Investments, Inc. 2,350,000
5.600%
2,350,000increase
(New Position)
Filing